LP
SRRA

LMR Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

LMR Partners’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,432
Closed -$299K – 1402
2022
Q2 		$299K Sell
5,432
-6,605
-55% -$347K 0.01% 1008
2022
Q1 		$386K Buy
+12,037
New +$345K ﹤0.01% 1036

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

LMR Partners's SRRA Position: Q3 2022 in Review

LMR Partners sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 5,432 shares — an estimated $299K sold.

LMR Partners first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $386K in Q1 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • LMR Partners reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • LMR Partners sold 5,432 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $299K.
  • LMR Partners first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • LMR Partners's Sierra Oncology, Inc. Common Stock position peaked at $386K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.